Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Mapping the conductivity of graphene with Electrical Resistance Tomography.

Cultrera A, Serazio D, Zurutuza A, Centeno A, Txoperena O, Etayo D, Cordon A, Redo-Sanchez A, Arnedo I, Ortolano M, Callegaro L.

Sci Rep. 2019 Jul 23;9(1):10655. doi: 10.1038/s41598-019-46713-8.

2.

Impact of continuous positive airway pressure on the pulmonary changes promoted by immersion in water.

Rizzetti DA, Quadros JRB, Ribeiro BE, Callegaro L, Veppo AA, Wiggers GA, Peçanha FM.

J Bras Pneumol. 2017 Nov-Dec;43(6):409-415. doi: 10.1590/S1806-37562017000000088. English, Portuguese.

3.

Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.

Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello MC, Bosticardo M, Evangelio C, Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow DJ, Galy A, Miniero R, Finocchi A, Metin A, Banerjee PP, Orange JS, Galimberti S, Valsecchi MG, Biffi A, Montini E, Villa A, Ciceri F, Roncarolo MG, Naldini L.

Science. 2013 Aug 23;341(6148):1233151. doi: 10.1126/science.1233151. Epub 2013 Jul 11.

4.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Ciceri F, Bonini C, Stanghellini MT, Bondanza A, Traversari C, Salomoni M, Turchetto L, Colombi S, Bernardi M, Peccatori J, Pescarollo A, Servida P, Magnani Z, Perna SK, Valtolina V, Crippa F, Callegaro L, Spoldi E, Crocchiolo R, Fleischhauer K, Ponzoni M, Vago L, Rossini S, Santoro A, Todisco E, Apperley J, Olavarria E, Slavin S, Weissinger EM, Ganser A, Stadler M, Yannaki E, Fassas A, Anagnostopoulos A, Bregni M, Stampino CG, Bruzzi P, Bordignon C.

Lancet Oncol. 2009 May;10(5):489-500. doi: 10.1016/S1470-2045(09)70074-9. Epub 2009 Apr 1.

PMID:
19345145
5.

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG.

N Engl J Med. 2009 Jan 29;360(5):447-58. doi: 10.1056/NEJMoa0805817.

6.

Clinical improvement and normalized Th1 cytokine profile in early and long-term interferon-alpha treatment in a suspected case of hyper-IgE syndrome.

Benninghoff U, Cattaneo F, Aiuti A, Flores-D'Arcais A, Gelmetti C, Viscardi M, Callegaro L, Mirolo M, Ambrosi A, Roncarolo MG, Bacchetta R.

Pediatr Allergy Immunol. 2008 Sep;19(6):564-8. doi: 10.1111/j.1399-3038.2007.00683.x.

PMID:
18844858
7.

Effects of extremely low-frequency magnetic fields on L-glutamic acid aqueous solutions at 20, 40, and 60 microT static magnetic fields.

Alberto D, Busso L, Garfagnini R, Giudici P, Gnesi I, Manta F, Piragino G, Callegaro L, Crotti G.

Electromagn Biol Med. 2008;27(3):241-53. doi: 10.1080/15368370802344052.

PMID:
18821200
8.

Novel impedance cell for low conductive liquids: determination of bulk and interface contributions.

Becchi M, Callegaro L, Durbiano F, D'Elia V, Strigazzi A.

Rev Sci Instrum. 2007 Nov;78(11):113902.

PMID:
18052483
9.

Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.

Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M, Pescarollo A, Bondanza A, Peccatori J, Rossini S, Magnani Z, Salomoni M, Benati C, Ponzoni M, Callegaro L, Corradini P, Bregni M, Traversari C, Bordignon C.

Blood. 2007 Jun 1;109(11):4698-707. Epub 2007 Feb 27.

PMID:
17327416
10.

[Prevalence of Chlamydia pneumoniae in respiratory infections in children: an ambulatory diagnostic problem].

Ravaioli E, Rizzo V, Milocco C, Callegaro L, Suprani T, Cerasoli G, Battistini F, Casadei A, Cipolloni A, Pocecco M.

Pediatr Med Chir. 1998 Sep-Oct;20(5):329-32. Italian.

PMID:
10068981
11.

Ciliary neurotrophic factor-induced gene expression in human neuroblastoma cell lines.

Rossino P, Volpe G, Negro A, Callegaro L, Altruda F, Tarone G, Silengo L.

Neurochem Res. 1995 Jun;20(6):675-80.

PMID:
7566363
12.

Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders.

Massaro AR, Soranzo C, Bigon E, Battiston S, Morandi A, Carnevale A, Callegaro L.

Ital J Neurol Sci. 1994 Mar;15(2):105-8.

PMID:
8056551
13.

Structure-function studies of human ciliary neurotrophic factor.

Negro A, Corsa V, Corona G, Grandi C, Skaper SD, Callegaro L.

Neurochem Res. 1994 Feb;19(2):223-7.

PMID:
8183431
14.

In vitro evaluation of nanoparticle formulations containing gangliosides.

Polato L, Benedetti LM, Callegaro L, Couvreur P.

J Drug Target. 1994;2(1):53-9.

PMID:
8069584
15.

Human neutrophil chemokinesis and polarization induced by hyaluronic acid derivatives.

Campoccia D, Hunt JA, Doherty PJ, Zhong SP, Callegaro L, Benedetti L, Williams DF.

Biomaterials. 1993 Dec;14(15):1135-9.

PMID:
8130317
16.

Ganglioside composition changes in spongiform encephalopathies: analyses of 263K scrapie-infected hamster brains.

Di Martino A, Safar J, Callegaro L, Salem N Jr, Gibbs CJ Jr.

Neurochem Res. 1993 Aug;18(8):907-13.

PMID:
8371832
17.

Nerve growth factor antibodies recognize neurotrophin-3.

Negro A, Corsa V, Skaper SD, Callegaro L.

Neurochem Res. 1993 Jun;18(6):705-9.

PMID:
8510797
18.

Production and characterization of monoclonal antibodies to human ciliary neurotrophic factor with defined epitope recognition.

Cazzola F, Battiston S, Fabris M, Negro A, Soranzo C, Corona G, Callegaro L.

Hybridoma. 1993 Jun;12(3):259-70.

PMID:
7689533
19.

Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation.

Saggioro D, Sorio C, Calderazzo F, Callegaro L, Panozzo M, Berton G, Chieco-Bianchi L.

J Biol Chem. 1993 Jan 15;268(2):1368-75. Erratum in: J Biol Chem 1993 Mar 15;268(8):6064.

20.

Inhibition of CTL-line lysis after gangliosides treatment.

Pollis F, Bronte V, Mandruzzato S, Rosato A, Zambon A, Zanovello P, Zambello R, Callegaro L, Collavo D.

Pharmacol Res. 1992 Sep;26 Suppl 2:190-1. No abstract available.

PMID:
1409305
21.

Synthesis and purification of biologically active rat brain-derived neurotrophic factor from Escherichia coli.

Negro A, Corsa V, Moretto C, Skaper SD, Callegaro L.

Biochem Biophys Res Commun. 1992 Aug 14;186(3):1553-9.

PMID:
1510681
22.

Synthesis and preliminary characterisation of new esters of the bacterial polysaccharide gellan.

Crescenzi V, Dentini M, Segatori M, Tiblandi C, Callegaro L, Benedetti L.

Carbohydr Res. 1992 Jul 2;231:73-81.

PMID:
1394330
23.

Production of novel monoclonal antibodies against rabbit platelet factor four.

Cazzola F, Saggin L, Callegaro L.

Hybridoma. 1992 Feb;11(1):61-9.

PMID:
1737641
24.

Competitive binding assay for quantitative determination of GM1 ganglioside in plasma and cerebrospinal fluid.

Kirschner G, Bassan M, Facco MP, Ferrari G, Callegaro L.

J Pharm Biomed Anal. 1992 Feb-Mar;10(2-3):163-6.

PMID:
1391096
25.

Synthesis of the biologically active beta-subunit of human nerve growth factor in Escherichia coli.

Negro A, Martini I, Bigon E, Cazzola F, Minozzi C, Skaper SD, Callegaro L.

Gene. 1992 Jan 15;110(2):251-6.

PMID:
1537563
26.

Effect of parenteral administration of GM1 on cytokines and anti-ganglioside antibody patterns. Preliminary report in normal human individuals.

Gallo P, Piccinno MG, Tavolato B, Innocenti M, Callegaro L, Kirschner G, Bruno R, Chizzolini C, Fiori MG.

J Neuroimmunol. 1992 Jan;36(1):81-6.

PMID:
1735772
27.

Interleukin-1 beta regulates proenkephalin gene expression in astrocytes cultured from rat cortex.

Negro A, Tavella A, Facci L, Callegaro L, Skaper SD.

Glia. 1992;6(3):206-12.

PMID:
1478730
28.

Cloning and expression of human ciliary neurotrophic factor.

Negro A, Tolosano E, Skaper SD, Martini I, Callegaro L, Silengo L, Fiorini F, Altruda F.

Eur J Biochem. 1991 Oct 1;201(1):289-94.

29.

A simple method to detect contaminating peptides and amino acids in large-scale ganglioside preparations.

Corona G, Mattioli S, Di Martino A, Callegaro L.

Biologicals. 1991 Oct;19(4):311-6.

PMID:
1797042
30.

Synthesis, purification, and characterization of human ciliary neuronotrophic factor from E. coli.

Negro A, Corona G, Bigon E, Martini I, Grandi C, Skaper SD, Callegaro L.

J Neurosci Res. 1991 Jun;29(2):251-60.

PMID:
1890704
31.

Differences in induction of c-fos transcription by cholera toxin-derived cyclic AMP and Ca2+ signals in astrocytes and 3T3 fibroblasts.

Gabellini N, Facci L, Milani D, Negro A, Callegaro L, Skaper SD, Leon A.

Exp Cell Res. 1991 Jun;194(2):210-7.

PMID:
1851095
32.

Campylobacter infections, Guillain-Barré syndrome, and parenteral gangliosides.

Callegaro L, Jack DB, Samson JC.

Lancet. 1991 Mar 30;337(8744):789. No abstract available.

PMID:
1672406
33.
34.

Large scale purification and immunological characterization of human placental nerve growth factor.

Bigon E, Soranzo C, Minozzi C, Skaper SD, Callegaro L.

Neurochem Res. 1990 Dec;15(12):1197-202.

PMID:
1711163
35.

Purification and characterization of Fab fragments from anti-mouse NGF polyclonal antibodies.

Callegaro L, Skaper SD, Vantini G, Benvegnù D, Di Martino A, Schiavo N, Triban C, Minozzi C, Leon A.

J Mol Recognit. 1990 Oct-Dec;3(5-6):187-91.

PMID:
2096885
36.

Peripheral nerve regeneration through a novel bioresorbable nerve guide.

Favaro G, Bortolami MC, Cereser S, Doná M, Pastorello A, Callegaro L, Fiori MG.

ASAIO Trans. 1990 Jul-Sep;36(3):M291-4.

PMID:
2174684
37.

Chemical residues of ganglioside molecules involved in interactions with lymphocyte surface targets leading to CD4 masking and inhibition of mitogenic proliferation.

Grassi F, Lopalco L, Lanza P, Ciccomascolo F, Cazzola F, Di Martino A, Kirschner G, Callegaro L, Chieco-Bianchi L, Siccardi AG.

Eur J Immunol. 1990 Jan;20(1):145-50.

PMID:
1968389
38.

Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats.

Vantini G, Schiavo N, Di Martino A, Polato P, Triban C, Callegaro L, Toffano G, Leon A.

Neuron. 1989 Sep;3(3):267-73.

PMID:
2484338
39.

CD4 modulation and inhibition of HIV-1 infectivity induced by monosialoganglioside GM1 in vitro.

Chieco-Bianchi L, Calabrò ML, Panozzo M, De Rossi A, Amadori A, Callegaro L, Siccardi A.

AIDS. 1989 Aug;3(8):501-7.

PMID:
2478163
40.

Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.

Siccardi AG, Buraggi GL, Callegaro L, Colella AC, De Filippi PG, Galli G, Mariani G, Masi R, Palumbo R, Riva P, et al.

Cancer Res. 1989 Jun 1;49(11):3095-103.

41.

Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography.

Medici I, Di Martino A, Cella G, Callegaro L, Prosdocimi M.

Thromb Res. 1989 May 15;54(4):277-87.

PMID:
2763268
42.

Lack of suppression by gangliosides of humoral or cellular immunity in vivo.

Presti D, Callegaro L, Toffano G, Marcus DM.

J Neuroimmunol. 1989 May;22(3):233-9.

PMID:
2703525
43.

Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.

Riva P, Paganelli G, Callegaro L, Bartoli MG, Turci D, Benini S, Deleide G, Scassellati GA, Viale G, Siccardi AG.

Nucl Med Commun. 1988 Aug;9(8):577-89.

PMID:
3173916
44.

Alpha-fetoprotein monoclonal assay: preliminary clinical findings in a high risk population.

Pizzocolo G, Salmi A, Lanza E, Rangoni G, Gussago A, Dovis M, Callegaro L, Albertini A.

Int J Biol Markers. 1988 Jan-Mar;3(1):10-4.

PMID:
2470837
45.

Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.

Buraggi G, Callegaro L, Turrin A, Gennari L, Bombardieri E, Mariani G, Deleide G, Dovis M, Gasparini M, Doci R, et al.

Cancer Detect Prev. 1987;10(5-6):335-45.

PMID:
3568032
46.

Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.

Siccardi AG, Buraggi GL, Callegaro L, Mariani G, Natali PG, Abbati A, Bestagno M, Caputo V, Mansi L, Masi R, et al.

Cancer Res. 1986 Sep;46(9):4817-22.

47.

Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.

De Rossi A, Gallo P, Tavolato B, Callegaro L, Chieco-Bianchi L.

Acta Neurol Scand. 1986 Aug;74(2):161-4.

PMID:
3022528
48.

Radioimmunodetection of melanoma: preliminary results of a prospective study.

Buraggi G, Turrin A, Cascinelli N, Attili A, Gasparini M, Callegaro L, Ferrone S, Seregni E, Bombardieri E, Belli F.

Int J Biol Markers. 1986 Jan-Apr;1(1):47-54.

PMID:
2826619
49.

Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.

Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M, et al.

Cancer Res. 1985 Jul;45(7):3378-87.

50.

HBeAg/anti-HBe determination with a new monoclonal immunoradiometric assay.

Pizzocolo G, Giammatteo D, Barbieri U, Boniolo A, Callegaro L, Palla M, Albertini A.

Vox Sang. 1985;48(3):129-35.

PMID:
3984298

Supplemental Content

Loading ...
Support Center